HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 263 filers reported holding HAEMONETICS CORP in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,497,701 | -3.0% | 30,191 | +0.1% | 0.26% | -4.5% |
| Q1 2024 | $2,574,498 | -0.7% | 30,164 | -0.6% | 0.27% | +85.4% |
| Q4 2023 | $2,593,774 | +90275.4% | 30,333 | -5.4% | 0.14% | -7.7% |
| Q3 2023 | $2,870 | +5.2% | 32,051 | +0.1% | 0.16% | +13.9% |
| Q2 2023 | $2,727 | -11.2% | 32,019 | -13.7% | 0.14% | 0.0% |
| Q1 2023 | $3,071 | +54.4% | 37,123 | +46.8% | 0.14% | +42.7% |
| Q4 2022 | $1,989 | -99.9% | 25,286 | -0.4% | 0.10% | +5.5% |
| Q3 2022 | $1,880,000 | -27.2% | 25,391 | -12.0% | 0.09% | +28.2% |
| Q2 2020 | $2,584,000 | +263.4% | 28,852 | +304.8% | 0.07% | +238.1% |
| Q1 2020 | $711,000 | -92.1% | 7,128 | -92.1% | 0.02% | -89.2% |
| Q4 2018 | $9,002,000 | +27.6% | 89,968 | +46.1% | 0.19% | +55.2% |
| Q3 2018 | $7,056,000 | +80.9% | 61,576 | +41.6% | 0.12% | +86.6% |
| Q2 2018 | $3,900,000 | +389900.0% | 43,489 | +621171.4% | 0.07% | – |
| Q1 2018 | $1,000 | – | 7 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |